Drugs / TMT101
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06861543 | Mar → Dec 2025 overdue | non-small cell lung carcinoma | Peking Union Medical College Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMT101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06861543 ↗ |
| Route | Intramuscular | “TMT101 will be injected intramuscularly” NCT06861543 ↗ |